4.7 Article

Amplification of IL-21 signalling pathway through Bruton's tyrosine kinase in human B cell activation

Related references

Note: Only part of the references are listed.
Article Multidisciplinary Sciences

Chronic active B-cell-receptor signalling in diffuse large B-cell lymphoma

R. Eric Davis et al.

NATURE (2010)

Article Multidisciplinary Sciences

The Bruton tyrosine kinase inhibitor PCI-32765 blocks B-cell activation and is efficacious in models of autoimmune disease and B-cell malignancy

Lee A. Honigberg et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)

Review Pharmacology & Pharmacy

Kinase inhibitors as drugs for chronic inflammatory and immunological diseases: progress and challenges

Laura L. Rokosz et al.

EXPERT OPINION ON THERAPEUTIC TARGETS (2008)

Review Immunology

Cytokine signaling modules in inflammatory responses

John J. O'Shea et al.

IMMUNITY (2008)

Article Immunology

IL-21 is produced by NKT cells and modulates NKT cell activation and cytokine production

Jonathan M. Coquet et al.

JOURNAL OF IMMUNOLOGY (2007)

Article Medicine, General & Internal

Efficacy of B-cell-targeted therapy with rituximab in patients with rheumatoid arthritis

JCW Edwards et al.

NEW ENGLAND JOURNAL OF MEDICINE (2004)

Article Biochemical Research Methods

Cloning of short hairpin RNAs for gene knockdown in mammalian cells

PJ Paddison et al.

NATURE METHODS (2004)